Presbyopic Phakic Iols - 7 Years Follow Up

To evaluate the long-term safety, efficacy, and patient satisfaction of presbyopia-correcting phakic intraocular lenses (IOLs) over a 7+ year follow-up period.

Gemini Eye Clinics, Zlin, Czech Republic

Analysis included 26 eyes implanted with presbyopic phakic IOLs IPCL (EyeolUK) was conducted. At the time of implantation the patients were aged 35–58 years (mean: 48.0 ± 5.1 years). Surgical procedure was refine so the phakic IOL was folded by the optic up, implanted without OVD and no miosis was administered at the end of implantation. Preoperative and postoperative assessments included refractive outcomes, uncorrected and corrected distance visual acuity (UDVA, CDVA), near visual acuity (UNVA), contrast sensitivity, endothelial cell count, and subjective satisfaction. Patients were followed up for more than 7 years since the implantation. 

At 7+ years, 71% of eyes achieved at least 0.1 logMAR UDVA, and 83% reached 0.2 logMAR. Distance refraction improved from -7.1±3.0 D to -0.2±0.7 D at 3M and remained stable. CDVA remained stable and 0.0 logMAR was reached in 96% of eyes. UNVA outcomes showed 57% of eyes achieving Jaeger J1 and 71% reaching J2. Contrast sensitivity remained within normal ranges under photopic and mesopic conditions, with mesopic CS with glare being borderline. Endothelium cell count remained stable over the duration of follow up. Subjective satisfaction was high: All patients would undergo surgery again and recommend it to others. 

Presbyopic phakic IOLs provide safe and effective long-term correction for myopic presbyopes over 35 years old. Distance and near vision stabilize within three months. Surgical technique refinements have contributed to improved outcomes with minimal complications.